creatine
AssetAlso Creatine Monohydrate, Creatine+
Replenishes cellular phosphocreatine pools to maintain mitochondrial energy production and ATP homeostasis.
- Stage
- Phase 3
- Modality
- Supplement
- Target
- Oxidative phosphorylation
- 1
- Indication
- 40
- Trials
- 2
- Developers
Indications
1Amyotrophic lateral sclerosis
Phase 3, Unknown, NCT00069186, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains3
- Owner and partners2
- Trials40
- Evidence for its targets2
- Competitors1
- Aging relevance2
- Signals2
Every asset’s record: target, stage, trials and the evidence behind it.
Updated 10 Oct 2026, 4 sources